Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00691600 · ClinicalTrials.gov registry record · Phase 3

Management of Skin and Soft Tissue Abscesses in Pediatric Patients After Incision and Drainage

A Phase 3 study of Abscess, sponsored by Baylor College of Medicine.

Completed
Registry status
Phase 3
Development phase
23
Enrollment target
1
Study location

NCT00691600 is a Phase 3 study of Abscess that has completed, run by Baylor College of Medicine. The registered enrollment target is 23 participants, below the 388-participant average among 13 other Abscess trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00691600, a Phase 3 study of Abscess, has completed, sponsored by Baylor College of Medicine.

COMPLETED
Registry status
Phase 3
Development phase
23 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to compare rates of cure of abscesses with and without antibiotic treatment after incision and drainage. The purpose of this study is to compare successful rates of cure of abscesses less than 5 cm with antibiotic (oral TMP/SMX) versus non-antibiotic treatment after incision and drainage.

Conditions Studied

Interventions

  • DRUG Placebo
  • DRUG oral trimethoprim/sulfamethoxazole

Study Locations (1)

Texas

  • Texas Children's Hospital - Houston

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2007-12
Est. Completion 2010-04
Phase Phase 3

Sponsor

Baylor College of Medicine

616 total trials

What the Registry Record Tells You About NCT00691600

The ClinicalTrials.gov registry entry for NCT00691600 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 388-participant average among 13 other Abscess trials with a reported enrollment target (94% lower). The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Abscess appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT00691600 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT00691600 about?

NCT00691600 is a clinical study titled "Management of Skin and Soft Tissue Abscesses in Pediatric Patients After Incision and Drainage". The purpose of the study is to compare rates of cure of abscesses with and without antibiotic treatment after incision and drainage. The purpose of this study is to compare successful rates of cure of abscesses less than 5 cm with antibiotic (oral TMP/SMX) versus non-antibiotic treatment after incis...

What is the current status of trial NCT00691600?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 23 participants. The study started on 2007-12. Estimated completion is 2010-04.

What conditions does trial NCT00691600 study?

This clinical trial studies the following conditions: Abscess.

What interventions are being tested in trial NCT00691600?

The interventions under investigation include: Placebo (DRUG), oral trimethoprim/sulfamethoxazole (DRUG).

Who is sponsoring clinical trial NCT00691600?

This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00691600 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Abscess

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.